Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 810371, 11 pages
http://dx.doi.org/10.1155/2014/810371
Research Article

Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury

1Department of Pharmacology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK, Canada S7N 5E5
2Faculté de Pharmacie, Université de Montréal, Montréal, QC, Canada H3T 1J4
3Department of Physiology, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5
4Department of Clinical Chemistry, Medical University of Wroclaw, 50-556 Wroclaw, Poland

Received 27 May 2014; Accepted 25 June 2014; Published 24 July 2014

Academic Editor: Danuta Szczesna-Cordary

Copyright © 2014 Han-Bin Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. G. Spinale, J. S. Janicki, and M. R. Zile, “Membrane-associated matrix proteolysis and heart failure,” Circulation Research, vol. 112, no. 1, pp. 195–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. F. G. Spinale, “Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function,” Physiological Reviews, vol. 87, no. 4, pp. 1285–1342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. M. Ali, X. Fan, and R. Schulz, “Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease,” Trends in Cardiovascular Medicine, vol. 21, no. 4, pp. 112–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Y. Cheung, G. Sawicki, M. W. Wozniak, W. Wang, M. W. Radomski, and R. Schulz, “Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart,” Circulation, vol. 101, no. 15, pp. 1833–1839, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Gao, L. Chen, Z. Z. Lu et al., “Activation of alpha1B-adrenoceptors contributes to intermittent hypobaric hypoxia-improved post-ischemic myocardial performance via inhibiting MMP-2 activation,” American Journal of Physiology, 2014. View at Google Scholar
  6. P. Bencsik, J. Paloczi, G. F. Kocsis et al., “Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective,” Pharmacological Research, vol. 80, pp. 36–42, 2014. View at Google Scholar
  7. E. Haase, D. L. Bigam, Q. B. Nakonechny, D. Rayner, G. Korbutt, and P. Cheung, “Cardiac function, myocardial glutathione, and matrix metalloproteinase-2 levels in hypoxic newborn pigs reoxygenated by 21%, 50%, or 100% oxygen,” Shock, vol. 23, no. 4, pp. 383–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Wang, G. Sawicki, and R. Schulz, “Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2,” Cardiovascular Research, vol. 53, no. 1, pp. 165–174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. H. León, I. Baczkó, G. Sawicki, P. E. Light, and R. Schulz, “Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte,” British Journal of Pharmacology, vol. 153, no. 4, pp. 676–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Wang, C. J. Schulze, W. L. Suarez-Pinzon, J. R. B. Dyck, G. Sawicki, and R. Schulz, “Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury,” Circulation, vol. 106, no. 12, pp. 1543–1549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. M. Ali, W. J. Cho, B. Hudson, Z. Kassiri, H. Granzier, and R. Schulz, “Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury,” Circulation, vol. 122, no. 20, pp. 2039–2047, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Sawicki, H. Leon, J. Sawicka et al., “Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2,” Circulation, vol. 112, no. 4, pp. 544–552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Doroszko, D. Polewicz, V. J. J. Cadete et al., “Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction,” Shock, vol. 34, no. 6, pp. 592–600, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Doroszko, D. Polewicz, J. Sawicka, J. S. Richardson, P. Y. Cheung, and G. Sawicki, “Cardiac dysfunction in an animal model of neonatal asphyxia is associated with increased degradation of MLC1 by MMP-2,” Basic Research in Cardiology, vol. 104, no. 6, pp. 669–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. V. J. J. Cadete, J. Sawicka, J. S. Jaswal et al., “Ischemia/reperfusion-induced myosin light chain 1 phosphorylation increases its degradation by matrix metalloproteinase 2,” The FEBS Journal, vol. 279, no. 13, pp. 2444–2454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Q. Gao, G. Sawicki, W. L. Suarez-Pinzon et al., “Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction,” Cardiovascular Research, vol. 57, no. 2, pp. 426–433, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. J. Schulze, W. Wang, W. L. Suarez-Pinzon, J. Sawicka, G. Sawicki, and R. Schulz, “Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury,” Circulation, vol. 107, no. 19, pp. 2487–2492, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. I. A. Arenas, Y. Xu, P. Lopez-Jaramillo, and S. T. Davidge, “Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-α,” American Journal of Physiology: Cell Physiology, vol. 286, no. 4, pp. C779–C784, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. G. M. Risinger Jr., T. S. Hunt, D. L. Updike, E. C. Bullen, and E. W. Howard, “Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors,” The Journal of Biological Chemistry, vol. 281, no. 36, pp. 25915–25925, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Stawowy, C. Margeta, H. Kallisch et al., “Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-β1 involves furin-convertase,” Cardiovascular Research, vol. 63, no. 1, pp. 87–97, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Polewicz, V. J. J. Cadete, A. Doroszko et al., “Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction,” Journal of Cellular and Molecular Medicine, vol. 15, no. 5, pp. 1136–1147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. M. Ali, A. K. Chow, A. D. Kandasamy et al., “Mechanisms of cytosolic targeting of matrix metalloproteinase-2,” Journal of Cellular Physiology, vol. 227, no. 10, pp. 3397–3404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. B. G. Hughes, X. Fan, W. J. Cho, and R. Schulz, “MMP-2 is localized to the mitochondria-associated membrane of the heart,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, pp. H764–H770, 2014. View at Google Scholar
  24. N. Oshiro and E. Miyagi, Matrix Metalloproteinases: Biology, Functions, and Clinical Implications, Nova Science Publishers, Hauppauge, NY, USA, 2011.
  25. H. León, N. Bautista-López, J. Sawicka, and R. Schulz, “Hydrogen peroxide causes cardiac dysfunction independent from its effects on matrix metalloproteinase-2 activation,” Canadian Journal of Physiology and Pharmacology, vol. 85, no. 3-4, pp. 341–348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. J. Schulze, M. M. Castro, A. D. Kandasamy et al., “Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass,” Critical Care Medicine, vol. 41, pp. 2512–2520, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Light, Y. Shimoni, S. Harbison, W. Giles, and R. J. French, “Hypothyroidism decreases the ATP sensitivity of KATP channels from rat heart,” The Journal of Membrane Biology, vol. 162, no. 3, pp. 217–223, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. G. H. Borchert, M. Hlaváčková, and F. Kolář, “Pharmacological activation of mitochondrial BKCa channels protects isolated cardiomyocytes against simulated reperfusion-induced injury,” Experimental Biology and Medicine, vol. 238, no. 2, pp. 233–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Diaz and G. J. Wilson, “Studying ischemic preconditioning in isolated cardiomyocyte models,” Cardiovascular Research, vol. 70, no. 2, pp. 286–296, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. R. J. Diaz, C. Zobel, H. C. Cho et al., “Selective inhibition of inward rectifier K+ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes,” Circulation Research, vol. 95, no. 3, pp. 325–332, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. R. J. Diaz, V. A. Losito, G. D. Mao, M. K. Ford, P. H. Backx, and G. J. Wilson, “Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium,” Circulation Research, vol. 84, no. 7, pp. 763–775, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Fert-Bober, R. S. Basran, J. Sawicka, and G. Sawicki, “Effect of duration of ischemia on myocardial proteome in ischemia/reperfusion injury,” Proteomics, vol. 8, no. 12, pp. 2543–2555, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Fert-Bober, H. Leon, J. Sawicka et al., “Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion,” Basic Research in Cardiology, vol. 103, no. 5, pp. 431–443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. F. Steinberg, “Oxidative stress and sarcomeric proteins,” Circulation Research, vol. 112, no. 2, pp. 393–405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Doenst, T. D. Nguyen, and E. D. Abel, “Cardiac metabolism in heart failure: implications beyond ATP production,” Circulation Research, vol. 113, no. 6, pp. 709–724, 2013. View at Publisher · View at Google Scholar
  36. A. Nickel, J. Löffler, and C. Maack, “Myocardial energetics in heart failure,” Basic Research in Cardiology, vol. 108, no. 4, article 358, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Ge and J. Ren, “MTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism,” Journal of Cellular and Molecular Medicine, vol. 16, no. 3, pp. 616–626, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. W. C. Parks and R. P. Mecham, Matrix Metalloproteinases, Academic Press, San Diego, Calif, USA, 1998.
  39. G. Sawicki, “Synergistic effect of inhibitors of MMPs and ROS-dependent modifications of contractile proteins on protection hearts subjected to oxidative stress,” Current Pharmaceutical Design, vol. 20, no. 9, pp. 1345–1348, 2014. View at Publisher · View at Google Scholar
  40. A. D. Kandasamy, A. K. Chow, M. A. M. Ali, and R. Schulz, “Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix,” Cardiovascular Research, vol. 85, no. 3, pp. 413–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. L. Coker, C. V. Thomas, M. J. Clair et al., “Myocardial matrix metalloproteinase activity and abundance with congestive heart failure,” The American Journal of Physiology, vol. 274, no. 5, pp. H1516–H1523, 1998. View at Google Scholar · View at Scopus
  42. J. F. Fisher and S. Mobashery, “Recent advances in MMP inhibitor design,” Cancer and Metastasis Reviews, vol. 25, no. 1, pp. 115–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. H. Drummond, P. Beckett, P. D. Brown et al., “Preclinical and clinical studies of MMP inhibitors in cancer,” Annals of the New York Academy of Sciences, vol. 878, pp. 228–235, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Esparza, M. Kruse, J. Lee, M. Michaud, and J. A. Madri, “MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity,” The FASEB Journal, vol. 18, no. 14, pp. 1682–1691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Zhang, S. Bai, X. Zhang, H. Nagase, and M. P. Sarras Jr., “The expression of gelatinase A (MMP-2) is required for normal development of zebrafish embryos,” Development Genes and Evolution, vol. 213, no. 9, pp. 456–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Ratajska and J. P. Cleutjens, “Embryogenesis of the rat heart: the expression of collagenases,” Basic Research in Cardiology, vol. 97, no. 3, pp. 189–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. N. J. Caplen, “Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference,” Gene Therapy, vol. 11, no. 16, pp. 1241–1248, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Zheng, D. Lian, A. Wong et al., “Novel small interfering RNA-containing solution protecting donor organs in heart transplantation,” Circulation, vol. 120, no. 12, pp. 1099–1107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Zhang, M. Beduhn, X. Zheng et al., “Induction of alloimmune tolerance in heart transplantation through gene silencing of TLR adaptors,” American Journal of Transplantation, vol. 12, no. 10, pp. 2675–2688, 2012. View at Publisher · View at Google Scholar · View at Scopus